News

Forge Biologics announced a gene therapy development and manufacturing collaboration with Labcorp. As a result of this strategic collaboration, gene therapy clients across the…
Read More...

Kamada Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved its application to manufacture CYTOGAM (Cytomegalovirus Immune Globulin Intravenous ) (CMV-IGIV) at…
Read More...

Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, is pleased to announce that it has closed on an important land purchase in Wallonia, Belgium,…
Read More...

Vertex Pharmaceuticals Incorporated announced the U.S. Food and Drug Administration (FDA) approved KALYDECO (ivacaftor) for use in children with cystic fibrosis (CF) ages 1 month to…
Read More...

Magenta Therapeutics, Inc. and Dianthus Therapeutics, Inc. announced that they have entered into a definitive merger agreement to combine the companies in an all-stock transaction. The…
Read More...

Bristol Myers Squibb announced that the European Commission (EC) has granted approval for Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR)…
Read More...

BrightPath Biotherapeutics Co., Ltd., a clinical stage biotechnology company focused on the development of cell therapies derived from invariant natural killer T (iNKT) cells, and…
Read More...

Biogen Inc. announced that the U.S. Food and Drug Administration (FDA) has approved QALSODY (tofersen) 100 mg/15mL injection for the treatment of amyotrophic lateral sclerosis (ALS) in…
Read More...

Boehringer Ingelheim inaugurated its state-of-the-art Biologicals Development Center (BDC) in Biberach an der Riß, Germany. The new high-tech facility underlines the company’s strong…
Read More...

ALX Oncology Holdings Inc. announced it has entered into a clinical trial collaboration and supply agreement with Sanofi to evaluate the combination of evorpacept, a next generation…
Read More...

Lantheus Holdings, Inc. and POINT Biopharma Global, Inc. announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for 177Lu-PNT2002 for the treatment of…
Read More...

Oncotelic Therapeutics, Inc. announced a strategic partnership with Vectara, a company specializing in innovative Natural Language Understanding (NLU) technologies, to accelerate the…
Read More...

Genentech, a member of the Roche Group announced that the U.S. Food and Drug Administration (FDA) has approved Polivy (polatuzumab vedotin-piiq) in combination with Rituxan (rituximab),…
Read More...

ANGLE plc is delighted to announce it has signed an agreement with BioView Ltd. ("BioView") (BIOV.TA) to develop a liquid biopsy circulating tumor cell (CTC) HER2 assay for breast…
Read More...

AbbVie (NYSE: ABBV) today announced the European Commission (EC) approved RINVOQ (upadacitinib, 45 mg and 15 mg and 30 mg ) as the first oral Janus Kinase (JAK) inhibitor for the…
Read More...

Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, and Lunaphore, a Swiss life sciences…
Read More...

Merck, known as MSD outside the United States and Canada, and Prometheus Biosciences, Inc. announced that the companies have entered into a definitive agreement under which Merck,…
Read More...

Biogen Inc. and Denali Therapeutics Inc. announced that Biogen has exercised the option to license Denali’s Antibody Transport Vehicle (ATV): Amyloid beta program (ATV:Aβ). Accumulation…
Read More...

IPS HEART has been granted rare pediatric drug designation by the FDA for GIVI-MPC, a first-in-class stem cell therapeutic to create new skeletal muscle with 100% full length dystrophin…
Read More...

Twist Bioscience Corporation announced the launch of Twist T-cell Receptor (TCR), and Twist chimeric antigen receptor (CAR) Libraries. These new libraries provide researchers with the…
Read More...